A citation-based method for searching scientific literature

Maria Patrizia Mongiardi, Matilde Merolle, Valentina Fustaino, Andrea Levi, Maria Laura Falchetti. Aging Clin Exp Res 2021
Times Cited: 2







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A complex secretory program orchestrated by the inflammasome controls paracrine senescence.
Juan Carlos Acosta, Ana Banito, Torsten Wuestefeld, Athena Georgilis, Peggy Janich, Jennifer P Morton, Dimitris Athineos, Tae-Won Kang, Felix Lasitschka, Mindaugas Andrulis,[...]. Nat Cell Biol 2013
804
100

Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype.
Christopher D Wiley, Michael C Velarde, Pacome Lecot, Su Liu, Ethan A Sarnoski, Adam Freund, Kotaro Shirakawa, Hyung W Lim, Sonnet S Davis, Arvind Ramanathan,[...]. Cell Metab 2016
373
100

The dynamic nature of senescence in cancer.
Soyoung Lee, Clemens A Schmitt. Nat Cell Biol 2019
153
100

Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner.
Maria Beatrice Morelli, Consuelo Amantini, Massimo Nabissi, Claudio Cardinali, Matteo Santoni, Giovanni Bernardini, Angela Santoni, Giorgio Santoni. Oncotarget 2017
20
100

NOTCH1 mediates a switch between two distinct secretomes during senescence.
Matthew Hoare, Yoko Ito, Tae-Won Kang, Michael P Weekes, Nicholas J Matheson, Daniel A Patten, Shishir Shetty, Aled J Parry, Suraj Menon, Rafik Salama,[...]. Nat Cell Biol 2016
169
100

Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation.
Maria Patrizia Mongiardi, Giulia Radice, Maurizia Piras, Venturina Stagni, Simone Pacioni, Agnese Re, Sabrina Putti, Fabrizio Ferrè, Antonella Farsetti, Roberto Pallini,[...]. Oncogene 2019
15
100

The essence of senescence.
Thomas Kuilman, Chrysiis Michaloglou, Wolter J Mooi, Daniel S Peeper. Genes Dev 2010
100

Pathological neoangiogenesis depends on oxidative stress regulation by ATM.
Yuji Okuno, Ayako Nakamura-Ishizu, Kinya Otsu, Toshio Suda, Yoshiaki Kubota. Nat Med 2012
103
50

Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma.
J Duerinck, S Du Four, F Vandervorst, N D'Haene, M Le Mercier, A Michotte, A M Van Binst, H Everaert, I Salmon, F Bouttens,[...]. J Neurooncol 2016
19
50

A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
G P Dimri, X Lee, G Basile, M Acosta, G Scott, C Roskelley, E E Medrano, M Linskens, I Rubelj, O Pereira-Smith. Proc Natl Acad Sci U S A 1995
50

Multicenter, phase II study of axitinib, a selective second-generation inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, in patients with metastatic melanoma.
John Fruehauf, Jose Lutzky, David McDermott, Charles K Brown, Jean-Baptiste Meric, Brad Rosbrook, David R Shalinsky, Katherine F Liau, Andreas G Niethammer, Sinil Kim,[...]. Clin Cancer Res 2011
83
50

Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Dana D Hu-Lowe, Helen Y Zou, Maren L Grazzini, Max E Hallin, Grant R Wickman, Karin Amundson, Jeffrey H Chen, David A Rewolinski, Shinji Yamazaki, Ellen Y Wu,[...]. Clin Cancer Res 2008
415
50


Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms.
Federica Grillo, Tullio Florio, Francesco Ferraù, Elda Kara, Giuseppe Fanciulli, Antongiulio Faggiano, Annamaria Colao. Endocr Relat Cancer 2018
22
50

Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy.
Audrey Bellesoeur, Edith Carton, Jerome Alexandre, Francois Goldwasser, Olivier Huillard. Drug Des Devel Ther 2017
18
50

Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
Xin Hong, Feng Jiang, Steven N Kalkanis, Zheng Gang Zhang, Xuepeng Zhang, Xuguang Zheng, Tom Mikkelsen, Hao Jiang, Michael Chopp. J Exp Ther Oncol 2007
9
50

Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer.
Hope S Rugo, Alison T Stopeck, Anil A Joy, Stephen Chan, Shailendra Verma, Anna Lluch, Katherine F Liau, Sinil Kim, Paul Bycott, Brad Rosbrook,[...]. J Clin Oncol 2011
81
50

Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features.
N Belot, S Rorive, I Doyen, F Lefranc, E Bruyneel, R Dedecker, S Micik, J Brotchi, C Decaestecker, I Salmon,[...]. Glia 2001
82
50

Four faces of cellular senescence.
Francis Rodier, Judith Campisi. J Cell Biol 2011
50

Senescence-messaging secretome: SMS-ing cellular stress.
Thomas Kuilman, Daniel S Peeper. Nat Rev Cancer 2009
545
50

Senescent cells: New target for an old treatment?
Marco Demaria. Mol Cell Oncol 2017
8
50

A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315).
James I Geller, Elizabeth Fox, Brian K Turpin, Stuart L Goldstein, Xiaowei Liu, Charles G Minard, Rachel A Kudgus, Joel M Reid, Stacey L Berg, Brenda J Weigel. Cancer 2018
16
50

The senescence-associated secretory phenotype: the dark side of tumor suppression.
Jean-Philippe Coppé, Pierre-Yves Desprez, Ana Krtolica, Judith Campisi. Annu Rev Pathol 2010
50

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
171
50

ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib.
Lei-Lei Niu, Chuan-le Cheng, Ming-Yue Li, Sheng-Li Yang, Bao-Guang Hu, Charing C N Chong, Stephen L Chan, Jianwei Ren, George G Chen, Paul B S Lai. Cell Death Dis 2018
9
50

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.
Joanna Kaplon, Liang Zheng, Katrin Meissl, Barbara Chaneton, Vitaly A Selivanov, Gillian Mackay, Sjoerd H van der Burg, Elizabeth M E Verdegaal, Marta Cascante, Tomer Shlomi,[...]. Nature 2013
350
50

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.
Josep Garcia, Herbert I Hurwitz, Alan B Sandler, David Miles, Robert L Coleman, Regula Deurloo, Olivier L Chinot. Cancer Treat Rev 2020
93
50

Anti-Angiogenics: Current Situation and Future Perspectives.
Katja Zirlik, Justus Duyster. Oncol Res Treat 2018
57
50

Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan.
Laurent Grosse, Nicole Wagner, Alexander Emelyanov, Clement Molina, Sandra Lacas-Gervais, Kay-Dietrich Wagner, Dmitry V Bulavin. Cell Metab 2020
46
50

Modular Architecture of the STING C-Terminal Tail Allows Interferon and NF-κB Signaling Adaptation.
Carina C de Oliveira Mann, Megan H Orzalli, David S King, Jonathan C Kagan, Amy S Y Lee, Philip J Kranzusch. Cell Rep 2019
28
50

p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
K R Jones, L W Elmore, C Jackson-Cook, G Demasters, L F Povirk, S E Holt, D A Gewirtz. Int J Radiat Biol 2005
89
50

Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.
Yong Yu, Kolja Schleich, Bin Yue, Sujuan Ji, Philipp Lohneis, Kristel Kemper, Mark R Silvis, Nouar Qutob, Ellen van Rooijen, Melanie Werner-Klein,[...]. Cancer Cell 2018
47
50

MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells.
Xiaoyuan He, Aimin Yang, Daniel G McDonald, Ellen C Riemer, Kenneth N Vanek, Bradley A Schulte, Gavin Y Wang. Oncotarget 2017
31
50

Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence.
Selene Glück, Baptiste Guey, Muhammet Fatih Gulen, Katharina Wolter, Tae-Won Kang, Niklas Arndt Schmacke, Anne Bridgeman, Jan Rehwinkel, Lars Zender, Andrea Ablasser. Nat Cell Biol 2017
333
50

From discoveries in ageing research to therapeutics for healthy ageing.
Judith Campisi, Pankaj Kapahi, Gordon J Lithgow, Simon Melov, John C Newman, Eric Verdin. Nature 2019
170
50

The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment.
Chang Sup Lee, Juhwa Baek, Sun-Young Han. Molecules 2017
13
50

Is cellular senescence an example of antagonistic pleiotropy?
Stefano Giaimo, Fabrizio d'Adda di Fagagna. Aging Cell 2012
34
50

Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells.
Maria Beatrice Morelli, Consuelo Amantini, Matteo Santoni, Alessandra Soriani, Massimo Nabissi, Claudio Cardinali, Angela Santoni, Giorgio Santoni. Oncotarget 2015
34
50

Spatial and Temporal Control of Senescence.
Yoko Ito, Matthew Hoare, Masashi Narita. Trends Cell Biol 2017
58
50

Targeting senescent cells in translational medicine.
Marta Paez-Ribes, Estela González-Gualda, Gary J Doherty, Daniel Muñoz-Espín. EMBO Mol Med 2019
63
50

Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging.
Dena S Leeman, Katja Hebestreit, Tyson Ruetz, Ashley E Webb, Andrew McKay, Elizabeth A Pollina, Ben W Dulken, Xiaoai Zhao, Robin W Yeo, Theodore T Ho,[...]. Science 2018
159
50

Tumor Cell Escape from Therapy-Induced Senescence as a Model of Disease Recurrence after Dormancy.
Tareq Saleh, Liliya Tyutyunyk-Massey, David A Gewirtz. Cancer Res 2019
53
50

Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells.
Tosol Yu, Bong Jun Cho, Eun Jung Choi, Ji Min Park, Dan Hyo Kim, In Ah Kim. Oncotarget 2016
15
50

Dysfunctional telomeres trigger cellular senescence mediated by cyclic GMP-AMP synthase.
Salim Abdisalaam, Souparno Bhattacharya, Shibani Mukherjee, Debapriya Sinha, Kalayarasan Srinivasan, Mingrui Zhu, Esra A Akbay, Hesham A Sadek, Jerry W Shay, Aroumougame Asaithamby. J Biol Chem 2020
5
50

Immunity, inflammation, and cancer.
Sergei I Grivennikov, Florian R Greten, Michael Karin. Cell 2010
50

Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells.
X Wang, S C Wong, J Pan, S W Tsao, K H Fung, D L Kwong, J S Sham, J M Nicholls. Cancer Res 1998
110
50

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
Jean-Philippe Coppé, Christopher K Patil, Francis Rodier, Yu Sun, Denise P Muñoz, Joshua Goldstein, Peter S Nelson, Pierre-Yves Desprez, Judith Campisi. PLoS Biol 2008
50

Cellular Senescence Promotes Skin Carcinogenesis through p38MAPK and p44/42MAPK Signaling.
Fatouma Alimirah, Tanya Pulido, Alexis Valdovinos, Sena Alptekin, Emily Chang, Elijah Jones, Diego A Diaz, Jose Flores, Michael C Velarde, Marco Demaria,[...]. Cancer Res 2020
10
50


Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Lynne W Elmore, Xu Di, Catherine Dumur, Shawn E Holt, David A Gewirtz. Clin Cancer Res 2005
95
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.